Sumitomo Mitsui Trust Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $275M | Sell |
4,542,241
-662,879
| -13% | -$38.6M | 0.18% | 107 |
|
|
2025
Q4 | $281M | Sell |
5,205,120
-54,846
| -1% | -$2.64M | 0.16% | 118 |
|
|
2025
Q3 | $237M | Buy |
5,259,966
+114,313
| +2% | +$5.34M | 0.14% | 144 |
|
|
2025
Q2 | $238M | Buy |
5,145,653
+103,608
| +2% | +$5.09M | 0.15% | 143 |
|
|
2025
Q1 | $308M | Buy |
5,042,045
+361,007
| +8% | +$21M | 0.22% | 100 |
|
|
2024
Q4 | $265M | Buy |
4,681,038
+27,232
| +0.6% | +$1.52M | 0.18% | 116 |
|
|
2024
Q3 | $241M | Buy |
4,653,806
+90,837
| +2% | +$4.26M | 0.17% | 129 |
|
|
2024
Q2 | $190M | Sell |
4,562,969
-511,497
| -10% | -$22.9M | 0.14% | 149 |
|
|
2024
Q1 | $275M | Sell |
5,074,466
-519,626
| -9% | -$26.5M | 0.19% | 113 |
|
|
2023
Q4 | $287M | Buy |
5,594,092
+172,769
| +3% | +$9.07M | 0.21% | 99 |
|
|
2023
Q3 | $315M | Sell |
5,421,323
-131,794
| -2% | -$8.08M | 0.26% | 77 |
|
|
2023
Q2 | $355M | Sell |
5,553,117
-801,341
| -13% | -$53.7M | 0.28% | 74 |
|
|
2023
Q1 | $440M | Sell |
6,354,458
-595,671
| -9% | -$42M | 0.33% | 62 |
|
|
2022
Q4 | $500M | Sell |
6,950,129
-120,762
| -2% | -$9.11M | 0.4% | 45 |
|
|
2022
Q3 | $503M | Sell |
7,070,891
-60,792
| -0.9% | -$4.41M | 0.41% | 37 |
|
|
2022
Q2 | $549M | Sell |
7,131,683
-265,078
| -4% | -$20.2M | 0.42% | 41 |
|
|
2022
Q1 | $540M | Buy |
7,396,761
+88,154
| +1% | +$5.92M | 0.36% | 53 |
|
|
2021
Q4 | $456M | Sell |
7,308,607
-146,895
| -2% | -$8.62M | 0.28% | 78 |
|
|
2021
Q3 | $441M | Sell |
7,455,502
-595,693
| -7% | -$39.2M | 0.27% | 84 |
|
|
2021
Q2 | $538M | Sell |
8,051,195
-714,889
| -8% | -$46.6M | 0.32% | 69 |
|
|
2021
Q1 | $553M | Buy |
8,766,084
+149,676
| +2% | +$9.31M | 0.35% | 59 |
|
|
2020
Q4 | $534M | Sell |
8,616,408
-1,088,718
| -11% | -$66.9M | 0.35% | 60 |
|
|
2020
Q3 | $585M | Sell |
9,705,126
-1,039,853
| -10% | -$62.6M | 0.39% | 48 |
|
|
2020
Q2 | $627M | Sell |
10,744,979
-1,045,934
| -9% | -$62.6M | 0.44% | 44 |
|
|
2020
Q1 | $652M | Buy |
11,790,913
+1,263,572
| +12% | +$77.2M | 0.56% | 33 |
|
|
2019
Q4 | $671M | Buy |
10,527,341
+3,140,646
| +43% | +$180M | 0.53% | 36 |
|
|
2019
Q3 | $375M | Buy |
7,386,695
+134,804
| +2% | +$6.34M | 0.33% | 65 |
|
|
2019
Q2 | $329M | Buy |
7,251,891
+78,260
| +1% | +$3.65M | 0.29% | 72 |
|
|
2019
Q1 | $342M | Buy |
7,173,631
+469,453
| +7% | +$23.4M | 0.32% | 66 |
|
|
2018
Q4 | $342M | Buy |
6,704,178
+1,394,335
| +26% | +$74.9M | 0.37% | 58 |
|
|
2018
Q3 | $330M | Buy |
5,309,843
+179,607
| +4% | +$10.7M | 0.35% | 60 |
|
|
2018
Q2 | $284M | Buy |
5,130,236
+320,015
| +7% | +$17.3M | 0.33% | 67 |
|
|
2018
Q1 | $304M | Buy |
4,810,221
+21,521
| +0.4% | +$1.38M | 0.39% | 57 |
|
|
2017
Q4 | $293M | Buy |
4,788,700
+135,762
| +3% | +$8.49M | 0.38% | 54 |
|
|
2017
Q3 | $297M | Sell |
4,652,938
-95,124
| -2% | -$5.55M | 0.42% | 48 |
|
|
2017
Q2 | $265M | Sell |
4,748,062
-150,396
| -3% | -$8.18M | 0.39% | 49 |
|
|
2017
Q1 | $266M | Buy |
4,898,458
+8,550
| +0.2% | +$469K | 0.41% | 48 |
|
|
2016
Q4 | $286M | Sell |
4,889,908
-74,874
| -2% | -$4.09M | 0.47% | 40 |
|
|
2016
Q3 | $268M | Sell |
4,964,782
-163,364
| -3% | -$10.5M | 0.44% | 45 |
|
|
2016
Q2 | $377M | Buy |
5,128,146
+36,497
| +0.7% | +$2.58M | 0.65% | 33 |
|
|
2016
Q1 | $325M | Buy |
5,091,649
+461,421
| +10% | +$29.1M | 0.57% | 38 |
|
|
2015
Q4 | $322M | Sell |
4,630,228
-279,159
| -6% | -$18.4M | 0.58% | 37 |
|
|
2015
Q3 | $291M | Buy |
4,909,387
+216,143
| +5% | +$13.7M | 0.56% | 36 |
|
|
2015
Q2 | $311M | Buy |
4,693,244
+378,481
| +9% | +$24.9M | 0.56% | 36 |
|
|
2015
Q1 | $278M | Buy |
4,314,763
+395,279
| +10% | +$24.7M | 0.5% | 41 |
|
|
2014
Q4 | $233M | Sell |
3,919,484
-55,481
| -1% | -$3.13M | 0.45% | 46 |
|
|
2014
Q3 | $203M | Sell |
3,974,965
-2,234
| -0.1% | -$112K | 0.41% | 50 |
|
|
2014
Q2 | $193M | Sell |
3,977,199
-265,691
| -6% | -$13.1M | 0.4% | 53 |
|
|
2014
Q1 | $220M | Sell |
4,242,890
-63,408
| -1% | -$3.37M | 0.46% | 45 |
|
|
2013
Q4 | $230M | Sell |
4,306,298
-168,300
| -4% | -$8.57M | 0.48% | 43 |
|
|
2013
Q3 | $206M | Sell |
4,474,598
-4,766
| -0.1% | -$209K | 0.44% | 47 |
|
|
2013
Q2 | $199M | Buy |
+4,479,364
| New | +$194M | 0.45% | 46 |
|
Other funds holding BMY
VCM
VPM
Sumitomo Mitsui Trust Group's BMY Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, selling an estimated $38.6M and leaving 4,542,241 shares worth $275M. The position accounts for 0.18% of the portfolio, ranked #107.
Sumitomo Mitsui Trust Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $671M in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Sumitomo Mitsui Trust Group held 4,542,241 shares of Bristol-Myers Squibb worth $275M as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 662,879 Bristol-Myers Squibb shares in Q1 2026, an estimated $38.6M.
- Bristol-Myers Squibb made up 0.18% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #107 holding.
- Sumitomo Mitsui Trust Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Mitsui Trust Group's Bristol-Myers Squibb position peaked at $671M in Q4 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.